Last Chance Ga131020: Fmoc-thr(neu5acα(2-3)galβ(1-3)galnac)-oh (peracetate, Methyl Ester) - Why Pay More? [zeyArEBM]

Last Chance Ga131020: Fmoc-thr(neu5acα(2-3)galβ(1-3)galnac)-oh (peracetate, Methyl Ester) - Why Pay More? [zeyArEBM]

Welcome to our premium line of Tumor-Associated Carbohydrate Antigens (TACA) with the STF-antigen (also known as ST). This cutting-edge product is designed to cater to the specific needs of researchers and medical professionals in the field of cancer immunotherapy. The STF-antigen, a sialylated form of the truncated O-glycosylated core determinant TF, is a key player in tumor cell organotropic metastasis. Our GA131020 product features a highly purified, Fmoc-protected threonine residue, making it ideal for use in various applications, including antigen-specific therapeutic vaccines against cancers.

• High purity and high specificity for accurate experimental results
• Conveniently presented as a methyl ester, enhancing stability and ease of use
• Supports research in cancer immunotherapy and tumor biology

Product Properties and Specifications

Our Last Chance Ga131020: Fmoc-thr(neu5acα(2-3)galβ(1-3)galnac)-oh (peracetate, Methyl Ester) - Why Pay More? [zeyArEBM] is meticulously prepared to ensure optimal performance. This product is characterized by the following properties:

• Chemical formula: Nα-(Fluoren-9-ylmethoxycarbonyl)-O-[(methyl 5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranosylonate)-(2→3)-2,4,6-tri-O-acetyl-β-D-galactopyranosyl-(1→3)-2-N-acetamido-2-deoxy-4,6-di-O-acetyl-α-D-]-L-threonine
• Formula weight: 125760-33-0
• Solubility: DMSO, methanol, and water

These specifications make our product suitable for a wide range of experimental procedures, including immunoassays, in vitro assays, and more.

Applications and Benefits

The Last Chance Ga131020: Fmoc-thr(neu5acα(2-3)galβ(1-3)galnac)-oh (peracetate, Methyl Ester) - Why Pay More? [zeyArEBM] is a valuable tool for researchers and clinicians seeking to develop novel immunotherapies and diagnostics. Its practical applications include:

• Targeting immune responses to truncated O-glycan chains in tumor cells
• Developing antigen-specific therapeutic vaccines against various cancers
• Supporting the study of STF antigen's role in tumor cell organotropic metastasis

By utilizing this product, researchers can contribute to the advancement of cancer immunotherapy and improve patient outcomes.